IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Lonza Bags Manufacturing Contract Using Microreactor Technology

11:26 AM MDT | May 26, 2009 | Deepti Ramesh

Lonza says it has won a manufacturing contract with a big pharma company, and the manufacture of the product will be based on Lonza’s proprietary microreactor technology (MRT), enabling scale-up, clinical trials, and large-scale commercial quantities. Further details of the contract were not disclosed. MRT utilizes continuous flow processes based on plug flow reactors and it requires minimal reagent volumes while offering rapid dynamic responses and robustness, Lonza says. MRT offers new chemical routes, reduced solvent usage, higher yields than...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa